- Home
- AMBC vs MBX Comparison
AMBC vs MBX Comparison
Compare AMBC & MBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- MBX
- Stock Information
- Founded
- AMBC 1971
- MBX 2018
- Country
- AMBC United States
- MBX United States
- Employees
- AMBC N/A
- MBX N/A
- Industry
- AMBC Property-Casualty Insurers
- MBX
- Sector
- AMBC Finance
- MBX
- Exchange
- AMBC Nasdaq
- MBX NYSE
- Market Cap
- AMBC 388.0M
- MBX 347.9M
- IPO Year
- AMBC 1991
- MBX 2024
- Fundamental
- Price
- AMBC $7.31
- MBX $7.62
- Analyst Decision
- AMBC Strong Buy
- MBX Strong Buy
- Analyst Count
- AMBC 2
- MBX 5
- Target Price
- AMBC $17.00
- MBX $37.40
- AVG Volume (30 Days)
- AMBC 1.6M
- MBX 339.5K
- Earning Date
- AMBC 05-05-2025
- MBX 05-16-2025
- Dividend Yield
- AMBC N/A
- MBX N/A
- EPS Growth
- AMBC N/A
- MBX N/A
- EPS
- AMBC N/A
- MBX N/A
- Revenue
- AMBC $240,754,000.00
- MBX N/A
- Revenue This Year
- AMBC N/A
- MBX N/A
- Revenue Next Year
- AMBC N/A
- MBX N/A
- P/E Ratio
- AMBC N/A
- MBX N/A
- Revenue Growth
- AMBC 90.76
- MBX N/A
- 52 Week Low
- AMBC $6.33
- MBX $4.81
- 52 Week High
- AMBC $18.45
- MBX $27.50
- Technical
- Relative Strength Index (RSI)
- AMBC 39.40
- MBX N/A
- Support Level
- AMBC $6.41
- MBX N/A
- Resistance Level
- AMBC $7.08
- MBX N/A
- Average True Range (ATR)
- AMBC 0.46
- MBX 0.00
- MACD
- AMBC 0.05
- MBX 0.00
- Stochastic Oscillator
- AMBC 38.58
- MBX 0.00
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.
About MBX MBX BIOSCIENCES INC
MBX Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.